We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
122 hedge funds and large institutions have $697M invested in Lexicon Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 44 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 15
3% more funds holding
Funds holding: 119 → 122 (+3)
2.05% less ownership
Funds ownership: 101.53% → 99.48% (-2.1%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
36% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 44
39% less capital invested
Capital invested by funds: $1.15B → $697M (-$450M)
74% less call options, than puts
Call options by funds: $640K | Put options by funds: $2.44M
Holders
122
Holders Change
+3
Holders Change %
+2.52%
% of All Funds
2.72%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
18
Increased
28
Reduced
44
Closed
15
Calls
$640K
Puts
$2.44M
Net Calls
-$1.8M
Net Calls Change
-$833K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$2.61M |
| 2 |
Renaissance Technologies
New York
|
+$2.05M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$1.86M |
| 4 |
D.E. Shaw & Co
New York
|
+$1.4M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$1.15M |
Top Sellers
| 1 |
UBS AM
Chicago,
Illinois
|
-$6.98M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.88M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.19M |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.54M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.76M |
